![Feds Not Backing Away from Punishing CGx Testing Scams](https://www.g2intelligence.com/wp-content/uploads/2022/09/Oct22.LCA_.CGxCase-iStock-1800x1250-1-1080x675.jpg)
Feds Not Backing Away from Punishing CGx Testing Scams
Recent case shows that fraud and kickback schemes involving CGx testing continue to be on the federal enforcement radar.
Recent case shows that fraud and kickback schemes involving CGx testing continue to be on the federal enforcement radar.
In this week’s enforcement roundup, the former executive was convicted of healthcare fraud relating to mental health diagnosis and treatment.
The owner of several clinical labs and other businesses will pay big for the schemes that involved money laundering, kickbacks, and fraud.
Mark Schena was found guilty of defrauding investors, as well as running an illegal kickback and healthcare fraud scheme.
A recent study shows that combined cardiomyopathy and arrhythmia genetic testing catches things disease-specific testing would miss.